Eli Lilly: Strong Growth, Strategically Smart and Attractive After Setbacks!
The combination of strong structural growth, financial power, and targeted future investments makes Eli Lilly a compelling long-term investment.
The recent price correction offers an attractive entry opportunity.
Reading Time: 2 minutes
The stock of Eli Lilly (NYSE: LLY) remains, in my view, a high-quality growth asset with an attractive risk-return profile. With a forward P/E ratio of 26.9 for the coming 12 months, it is neither a bargain nor overly expensive. At the same time, the security is trading 18.2% below its all-time high from January 2026, which presents an interesting entry point when looking at LLY's historical drawdowns. Notably, the long-term performance is impressive: over the past nine years, Lilly has consistently achieved positive annual returns (2017-2025),...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

